Collectively, these findings indicate that in EGFR-mutant NSCLC cells, PLK1 predominantly modulates STAT3 through a phosphorylation-dependent mechanism rather than by regulating basal expression levels. Here, PLK1 is linked to non-small cell lung carcinoma.